Loading...
BONEX logo

Bonesupport Holding Community

OM:BONEX Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author

Community Investing Ideas

BONEX logo
Bonesupport Holding

FDA Submission And US Launch Will Drive Success

Key Takeaways High repeat usage and indication expansion in the U.S. drive strong growth for CERAMENT G, enhancing future revenue prospects and market share. Upcoming FDA approvals and reimbursement adjustments, alongside strategic marketing investments, are expected to boost revenue and margins across underpenetrated markets.

View narrative
0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
SEK 419.75
34.5% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
35.23% p.a.
Profit Margin
32.11%
Future PE
37.93x
Share price in 2028
SEK 484.62